On Wednesday, TD Ameritrade Holding Corp. (NYSE:AMTD)’s shares inclined 1.24% to $32.53.
Investors can assist build confidence, improve investing skills and learn from some of recently’s top industry market professionals at the 2015 Investor Education Conference by Investools® from TD Ameritrade Holding Corporation (AMTD).
The Investools Investor Education Conference 2015 will be held at the Hilton Anaheim Hotel in Anaheim, CA. from Aug. 24-26, 2015. In addition to in-depth breakout sessions, attendees will have the opportunity to learn from industry veterans, network with other investors and discover new strategies to assist build investor confidence.
TD Ameritrade Holding Corporation provides securities brokerage services and related technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. Its products and services comprise tdameritrade.com, a Web platform for self-directed retail investors; Trade Architect, a Web-based platform that enables active investors and traders identify opportunities and stay informed; thinkorswim, a desktop platform for trading; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts from Web-enabled mobile devices.
Travelers Companies Inc(NYSE:TRV)’s shares gained 1.48% to $98.93.
A.M. Best has assigned an issue rating of “a+” to the $400 million 4.3% senior unsecured notes, due 2045, recently issued by The Travelers Companies, Inc. (TRV) (New York, NY) [NYSE:TRV]. The outlook assigned is stable.
The proceeds from the sale of the notes will be used to pay off the existing $400 million 5.5% senior unsecured notes, due Dec. 1, 2015. The debt offering is following a shelf registration statement filed with the Securities and Exchange Commission. While Travelers’ financial leverage will modestly enhance in the near term, it will remain within A.M. Best’s guidelines to support its current ratings. A.M. Best anticipates Travelers’ coverage ratios to remain strong and well supportive of the current rating.
The Travelers Companies, Inc., through its auxiliaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the Unites states and internationally. It operates in three segments: Business and International Insurance; Bond & Specialty Insurance; and Personal Insurance.
At the end of Wednesday’s trade, Allergan PLC (NYSE:AGN)‘s shares surged 1.84% to $299.61.
Allergan plc (AGN) stated continued exceptional performance with net revenue increasing 116 percent to $5.76 billion for the quarter ended June 30, 2015, contrast to $2.67 billion in the second quarter 2014. On a non-GAAP basis, diluted earnings per share raised 29 percent to $4.41 for the second quarter 2015, contrast to $3.42 in the second quarter 2014. GAAP loss per share for the second quarter 2015 was $0.80, contrast to GAAP income per diluted share of $0.28 in the preceding year period. GAAP results were influenced by amortization, in-process research and development impairments, acquisition-related expenses, acquisition accounting valuation related expenses and severance and integration costs associated with attained businesses, mainly the acquisitions of Allergan on March 17, 2015 and Forest Laboratories on July 1, 2014.
Other Operating Results
For the second quarter 2015, non-GAAP gross margin was 72.3 percent contrast to 56.3 percent in the second quarter of 2014, reflecting the impact of the Allergan acquisition. Total non-GAAP SG&A as a percent of non-GAAP revenue for the second quarter 2015 was 21.7% contrast to 18.7% in the preceding year period. For the second quarter 2015, non-GAAP R&D spending was $406.0 million contrast to $184.8 million in the preceding year. Adjusted EBITDA raised 203 percent to $2.61 billion in the second quarter of 2015, contrast to $862.0 million for the second quarter 2014. Cash flow from operations for the second quarter of 2015 was $1.4 billion and cash and marketable securities were $1.5 billion as of June 30, 2015.
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment provides patented and off-patent trademarked pharmaceutical products primarily under the Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo Loestrin Fe, and Minastrin 24 Fe brands.
Sempra Energy(NYSE:SRE), ended its Wednesday’s trading session with -0.24% loss, and closed at $92.00.
Sempra Energy (SRE) awarded $1,000,000 in grants to over 87 regional safety partners as part of SAFE San Diego, a SDG&E philanthropic initiative aimed at supporting non-profit organizations dedicated to disaster preparedness, emergency response training, wildfire education, and defensible space assistance programs.
Sempra Energy operates as an energy services holding company worldwide. The company’s San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of February 23, 2015, this segment offered energy service about to 3.4 million consumers through 1.4 million electric meters and 878,000 natural gas meters in San Diego and southern Orange counties. Its Southern California Gas Company segment transmits, distributes, and stores natural gas. As of February 6, 2015, this segment served about to 21 million consumers through 5.8 million meters in 500 communities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
